Instylla
PrivateLast Round
Early Stage
VC
Jul 28, 2026
Est. Valuation
$125.43M
Total Funding Raised
$81.96M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Instylla is a medical device company that develops liquid embolic solutions for interventional radiology, aimed at providing controlled and effective embolization to enhance patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Instylla Comparables
Compare Instylla with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fluidx Medical Technology | 84% | |
| ABK Biomedical | 81% | |
| Cortex, Inc. | 79% | |
Instylla Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jul 28, 2026 | ||||
| Series C | Aug 1, 2023 | ||||
| Series B | Oct 13, 2020 | ||||
| Debt | Apr 28, 2020 | ||||
| Series A Extension | Jun 12, 2018 | ||||
Series A | Jun 6, 2017 |
Instylla Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Incept LLC | Series C, Series A, Series B |
| Ascension Ventures | Series C, Series A, Series B |
| CHV | Series C, Series B |
| Incept AI | Series C, Series B |
| Sparta Group LLC | Series C, Series B |
| Catalyst Health Ventures | Series C, Series A, Series B |
| Excelestar Ventures | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Embrace(TM) Hydrogel Embolic System approved for tumor embolization.
- Jan 1, 2026
Embrace(TM) Hydrogel Embolic System approved for tumor embolization.
Instylla Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Instylla's valuation, stock price, and market status.